PPARG and metabolic dysfunction-associated steatotic liver disease: In db/db mice with NAFLD, ginsenoside Re exerts its protective effects possibly through the inhibition of oxidative stress and the upregulation of peroxisome proliferator - activated receptor γ (PPARγ) expression (Jiang et al., 2021).